Vanguard Group
NUTX

Vanguard Group’s Nutex Health NUTX Stock Holding History

Vanguard Group’s Portfolio NUTX Stock Details NUTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$42.6M Buy
258,743
+43,789
+20% +$5.81M ﹤0.01% 2258
2025
Q3 		$22.2M Buy
214,954
+24,275
+13% +$2.38M ﹤0.01% 2569
2025
Q2 		$23.7M Buy
190,679
+55,868
+41% +$7.22M ﹤0.01% 2481
2025
Q1 		$6.34M Buy
134,811
+19,755
+17% +$964K ﹤0.01% 3080
2024
Q4 		$3.65M Buy
115,056
+23,094
+25% +$658K ﹤0.01% 3382
2024
Q3 		$2M Buy
91,962
+163
+0.2% +$2.35K ﹤0.01% 3557
2024
Q2 		$546K Buy
91,799
+5,423
+6% +$39.1K ﹤0.01% 3977
2024
Q1 		$1.24M Buy
86,376
+1,951
+2% +$39.3K ﹤0.01% 3739
2023
Q4 		$2.28M Sell
84,425
-916
-1% -$28.6K ﹤0.01% 3556
2023
Q3 		$2.59M Buy
85,341
+20,525
+32% +$990K ﹤0.01% 3501
2023
Q2 		$4.1M Sell
64,816
-5,535
-8% -$475K ﹤0.01% 3395
2023
Q1 		$10.7M Buy
70,351
+60,560
+619% +$12.3M ﹤0.01% 2903
2022
Q4 		$2.79M Buy
9,791
+8,551
+690% +$1.64M ﹤0.01% 3542
2022
Q3 		$278K Sell
1,240
-9
-0.7% -$3.82K ﹤0.01% 4361
2022
Q2 		$604K Buy
+1,249
New +$1.47M ﹤0.01% 4236

Other funds holding NUTX

TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
OPOWM
One Plus One Wealth Management Jupiter, Florida $232M AUM 28.06% 1-Year Est. Return

Vanguard Group's NUTX Position: Q4 2025 in Review

Vanguard Group increased its Nutex Health (NUTX) stake by 20% in Q4 2025, buying an estimated $5.81M and bringing the position to 258,743 shares worth $42.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2258.

Vanguard Group first reported a position in NUTX in Q2 2022 and has held it in 15 quarters since. 117 funds tracked by Wall St. Rank hold NUTX as of Q4 2025.

  • Vanguard Group held 258,743 shares of Nutex Health worth $42.6M as of Q4 2025.
  • Vanguard Group bought 43,789 Nutex Health shares in Q4 2025, an estimated $5.81M.
  • Nutex Health made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #2258 holding.
  • Vanguard Group first reported a position in Nutex Health in Q2 2022 and has held it in 15 quarters since.
  • 117 funds tracked by Wall St. Rank held Nutex Health as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.